Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ines B Moura

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Antimicrobial Agents and Chemotherapy|November 21, 2018
Omadacycline Gut Microbiome Exposure Does Not Induce Clostridium difficile Proliferation or Toxin Production in a Model That Simulates the Proximal, Medial, and Distal Human ColonInes B Moura, Anthony M Buckley, Duncan Ewin, et al.
BMC Microbiology|January 4, 2020
Method comparison for the direct enumeration of bacterial species using a chemostat model of the human colonInes B Moura, Charmaine Normington, Duncan Ewin, et al.
Nature Reviews. Microbiology|October 2, 2025
Clostridioides difficile pathogenesis and controlCaroline H Chilton, Virginie Viprey, Charmaine Normington, et al.
Frontiers in Microbiology|June 17, 2022
Profiling the Effects of Systemic Antibiotics for Acne, Including the Narrow-Spectrum Antibiotic Sarecycline, on the Human Gut MicrobiotaInes B Moura, Ayman Grada, William Spittal, et al.
Microbial Biotechnology|April 10, 2023
MiGut: A scalable in vitro platform for simulating the human gut microbiome-Development, validation and simulation of antibiotic-induced dysbiosisWilliam A Davis Birch, Ines B Moura, Duncan J Ewin, et al.
Sexually Transmitted Diseases|June 10, 2021
Utility of Whole Genome Sequencing in Assessing and Enhancing Partner Notification of Neisseria gonorrhoeae InfectionLing Yuan Kong, Janet D Wilson, Ines B Moura, et al.
The Journal of Antimicrobial Chemotherapy|September 25, 2021
The use of first-generation cephalosporin antibiotics, cefalexin and cefradine, is not associated with induction of simulated Clostridioides difficile infectionAnthony M Buckley, Ines B Moura, James Altringham, et al.
The Journal of Antimicrobial Chemotherapy|September 15, 2020
Eravacycline, a novel tetracycline derivative, does not induce Clostridioides difficile infection in an in vitro human gut modelAnthony M Buckley, James Altringham, Emma Clark, et al.
Ebiomedicine|May 1, 2019
Clostridium difficile trehalose metabolism variants are common and not associated with adverse patient outcomes when variably present in the same lineageDavid W Eyre, Xavier Didelot, Anthony M Buckley, et al.
Frontiers in Cellular and Infection Microbiology|July 19, 2021
Trehalose-Induced Remodelling of the Human Microbiota Affects <i>Clostridioides difficile</i> Infection Outcome in an <i>In Vitro</i> Colonic Model: A Pilot StudyAnthony M Buckley, Ines B Moura, Norie Arai, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Antimicrobial Agents and Chemotherapy|November 21, 2018
Omadacycline Gut Microbiome Exposure Does Not Induce Clostridium difficile Proliferation or Toxin Production in a Model That Simulates the Proximal, Medial, and Distal Human ColonInes B Moura, Anthony M Buckley, Duncan Ewin, et al.
BMC Microbiology|January 4, 2020
Method comparison for the direct enumeration of bacterial species using a chemostat model of the human colonInes B Moura, Charmaine Normington, Duncan Ewin, et al.
Nature Reviews. Microbiology|October 2, 2025
Clostridioides difficile pathogenesis and controlCaroline H Chilton, Virginie Viprey, Charmaine Normington, et al.
Frontiers in Microbiology|June 17, 2022
Profiling the Effects of Systemic Antibiotics for Acne, Including the Narrow-Spectrum Antibiotic Sarecycline, on the Human Gut MicrobiotaInes B Moura, Ayman Grada, William Spittal, et al.
Microbial Biotechnology|April 10, 2023
MiGut: A scalable in vitro platform for simulating the human gut microbiome-Development, validation and simulation of antibiotic-induced dysbiosisWilliam A Davis Birch, Ines B Moura, Duncan J Ewin, et al.
Sexually Transmitted Diseases|June 10, 2021
Utility of Whole Genome Sequencing in Assessing and Enhancing Partner Notification of Neisseria gonorrhoeae InfectionLing Yuan Kong, Janet D Wilson, Ines B Moura, et al.
The Journal of Antimicrobial Chemotherapy|September 25, 2021
The use of first-generation cephalosporin antibiotics, cefalexin and cefradine, is not associated with induction of simulated Clostridioides difficile infectionAnthony M Buckley, Ines B Moura, James Altringham, et al.
The Journal of Antimicrobial Chemotherapy|September 15, 2020
Eravacycline, a novel tetracycline derivative, does not induce Clostridioides difficile infection in an in vitro human gut modelAnthony M Buckley, James Altringham, Emma Clark, et al.
Ebiomedicine|May 1, 2019
Clostridium difficile trehalose metabolism variants are common and not associated with adverse patient outcomes when variably present in the same lineageDavid W Eyre, Xavier Didelot, Anthony M Buckley, et al.
Frontiers in Cellular and Infection Microbiology|July 19, 2021
Trehalose-Induced Remodelling of the Human Microbiota Affects <i>Clostridioides difficile</i> Infection Outcome in an <i>In Vitro</i> Colonic Model: A Pilot StudyAnthony M Buckley, Ines B Moura, Norie Arai, et al.
Pageof 3